Table 1 Baseline Demographics.
All (n = 332) | UG (n = 109) | EG (n = 181) | SG (n = 42) | P-value between subtypes | ||
|---|---|---|---|---|---|---|
Mean age, yrs (SD) | 69 ± 14 | 63 ± 14 | 76 ± 8 | 55 ± 16 | <0.0001 | |
Gender, n (%) | ||||||
Male | 180 (54%) | 56 (51%) | 99 (55%) | 25 (60%) | 0.65 | |
Female | 152 (46%) | 53 (49%) | 82 (45%) | 17 (40%) | ||
Visual acuity, logMAR (SD) | 0.19 ± 0.41 | 0.29 ± 0.50 | 0.15 ± 0.36 | 0.06 ± 0.22 | 0.02 | |
MD, dB (SD) | −11.0 ± 9.6 | −12.4 ± 9.7 | −10.6 ± 9.6 | −10.0 ± 9.2 | 0.50 | |
PSD, dB (SD) | 7.0 ± 4.3 | 7.5 ± 4.5 | 7.0 ± 4.3 | 5.8 ± 3.8 | 0.45 | |
Lens status (phakia), n (%) | 203 (61%) | 63 (58%) | 108 (60%) | 32 (76%) | 0.10 | |
Baseline IOP, mmHg (SD) | 23.8 ± 9.0 | 27.5 ± 10.0 | 21.0 ± 7.2 | 26.8 ± 9.3 | <0.0001 | |
Antiglaucoma eye drops at baseline (SD) | 3.0 ± 1.2 | 2.9 ± 1.1 | 3.1 ± 1.3 | 2.7 ± 1.2 | 0.17 | |
